BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution

  • Chengyan Chai
  • , Ke Sui
  • , Jun Tang
  • , Hao Yu
  • , Chao Yang
  • , Hongyang Zhang
  • , Shengwen Calvin Li
  • , Jiang F. Zhong
  • , Zheng Wang
  • , Xi Zhang

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)3943-3963
Number of pages21
JournalTheranostics
Volume13
Issue number12
DOIs
StatePublished - 2023

ASJC Scopus Subject Areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Keywords

  • B progenitor acute lymphoblastic leukemia
  • BCR-ABL1
  • Cx43
  • MSCs
  • acute lymphoblastic leukemia
  • chemotherapy resistance
  • gap junctions
  • leukemic microenvironment
  • miR-130a and miR-130b
  • stemness
  • Humans
  • Phosphatidylinositol 3-Kinases/metabolism
  • Exosomes/metabolism
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy
  • Cell Communication/genetics
  • Connexin 43/metabolism
  • Tumor Microenvironment/genetics
  • Tumor Suppressor Proteins/metabolism
  • MicroRNAs/metabolism

Cite this